comparemela.com
Latest Breaking News On - Management departmente mail - Page 1 : comparemela.com
MEDRx : Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
News Release Dated April 24, 2024 MedRx Co., Ltd. Yonehiro Matsumura, CEO Stock code: 4586, TSE Growth .
Yonehiro-matsumura
Medrx-co-ltd
Management-department
Inhibitor-in-development
Medrx-company
Alto-neuroscience-inc
Medrx-company-limited
News-release-dated-april
Collaboration-partner
Alto-neuroscience
Announces-positive-phase
Company-limited
MedRx : Prospect of NDA Re-Submission for MRX-5LBT -October 10, 2023 at 02:04 am EDT
News Release Dated October 10, 2023 MEDRx Co., Ltd. Yonehiro Matsumura, CEO Stock code: 4586, TSE Growth .
United-states
Yonehiro-matsumura
Drug-administration
D-western-therapeutics-institute-inc
Management-department
Medrx-co-ltd
News-release-dated-october
New-drug-application
Complete-response-letter
Therapeutics-institute
Ionic-liquid-transdermal-system
Management-departmente-mail
vimarsana © 2020. All Rights Reserved.